Abstract:Stress granules (SGs), hallmarks of the cellular adaptation to stress, promote survival, conserve cellular energy, and are fully dissolved upon the cessation of stress treatment. Different stresses can initiate the assembly of SGs, but arsenite and heat are the best studied of these stresses. The composition of SGs and posttranslational modifications of SG proteins differ depending on the type and severity of the stress insult, methodology used, cell line, and presence of overexpressed and tagged proteins. A group of 18 proteins showing differential localization to SGs in heat‐ and arsenite‐stressed mammalian cell lines is described. Upon severe and prolonged stress, physiological SGs transform into more solid protein aggregates that are no longer reversible and do not contain mRNA. Similar pathological inclusions are hallmarks of neurodegenerative diseases. SGs induced by heat stress are less dynamic than SGs induced by arsenite and contain a set of unique proteins and linkage‐specific polyubiquitinated proteins. The same types of ubiquitin linkages have been found to contribute to the development of neurodegenerative disorders such as Parkinson disease, Alzheimer disease, and amyotrophic lateral sclerosis (ALS). We propose heat stress‐induced SGs as a possible model of an intermediate stage along the transition from dynamic, fully reversible arsenite stress‐induced SGs toward aberrant SGs, the hallmark of neurodegenerative diseases. Stress‐ and methodology‐specific differences in the compositions of SGs and the transition of SGs to aberrant protein aggregates are discussed.This article is categorized under:RNA in Disease and Development > RNA in DiseaseRNA Interactions with Proteins and Other Molecules > RNA–Protein ComplexesRNA Export and Localization > RNA Localization

An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function

Aberrant Stress Granule Dynamics and Aggrephagy in ALS Pathogenesis

Friend or Foe: the Role of Stress Granule in Neurodegenerative Disease

Small molecule modulation of a redox-sensitive stress granule protein dissolves stress granules with beneficial outcomes for familial amyotrophic lateral sclerosis models

ALS-associated FUS mutation reshapes the RNA and protein composition of Stress Granules

Stress granules and neurodegeneration

A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation

Stress granules in the spinal muscular atrophy and amyotrophic lateral sclerosis: The correlation and promising therapy

A liquid-to-solid phase transition of Cu/Zn superoxide dismutase 1 initiated by oxidation and disease mutation

Solid-to-liquid phase transition in the dissolution of cytosolic misfolded-protein aggregates

Lsm7 phase-separated condensates trigger stress granule formation

Molecular Chaperones' Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis

Changing faces of stress: Impact of heat and arsenite treatment on the composition of stress granules

Aberrant Phase Separation of FUS Leads to Lysosome Sequestering and Acidification

Metastable condensates suppress conversion to amyloid fibrils

<i>In vivo</i> stress granule misprocessing evidenced in a FUS knock-in ALS mouse

The involvement of stress granules in aging and aging‐associated diseases

Role of Proteostasis Regulation in the Turnover of Stress Granules

Proteostasis impairment in ALS

Energy scarcity and impaired mitochondrial translation induce perinuclear stress granule clustering

Stress granule formation helps to mitigate neurodegeneration